CeriBell, Inc. (CBLL) vs Corvus Pharmaceuticals, Inc. (CRVS)
A side-by-side comparison of CeriBell, Inc. and Corvus Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CBLL
CeriBell, Inc.
$24.61HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
CRVS
Corvus Pharmaceuticals, Inc.
$10.56HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — CBLL vs CRVS
growth of $100 · dividends reinvested · last 2yCBLL -0.6% (-0.3%/yr)CRVS +79.3% (+33.9%/yr)CRVS compounded faster over this window
CBLL CRVS
CBLL vs CRVS: by the numbers
- •CBLL is the larger company ($934M vs $888M market cap).
- •Both run net losses; CRVS's is the smaller (0.00% vs -64.73% net margin).
Metrics side by side
Valuation
| Metric | CBLL | CRVS |
|---|---|---|
| P/S ratio | 9.16 | N/A |
| P/B ratio | 7.28 | 3.94 |
Profitability
| Metric | CBLL | CRVS |
|---|---|---|
| Gross margin | 88.90% | 0.00% |
| Operating margin | -68.62% | 0.00% |
| Net margin | -64.73% | 0.00% |
| ROE | -51.43% | -24.02% |
| ROIC | -46.54% | -25.25% |
Growth (annualized)
| Metric | CBLL | CRVS |
|---|---|---|
| Total return CAGR (5Y) | N/A | 17.88% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.